Clinical Trials for GDC-0032
1 Open Trial
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | VICCPHI1248 10/12/2012 | An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety and Tolerability of GDC0032 in Patients with Locally Advanced or Metastatic Solid Tumors and in Combination with Endocrine Therapy in Patients with Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
